Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Decreases By 67.7%

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 501,400 shares, a drop of 67.7% from the August 15th total of 1,550,000 shares. Based on an average daily volume of 4,920,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.7% of the company’s stock are sold short. Approximately 3.7% of the company’s stock are sold short. Based on an average daily volume of 4,920,000 shares, the days-to-cover ratio is currently 0.1 days.

BiomX Price Performance

Shares of BiomX stock opened at $0.51 on Friday. BiomX has a 1 year low of $0.34 and a 1 year high of $1.16. The stock has a market cap of $13.52 million, a P/E ratio of -0.37 and a beta of 1.39. The stock’s fifty day simple moving average is $0.48.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and issued a $15.00 price objective on shares of BiomX in a report on Wednesday, August 20th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, BiomX has a consensus rating of “Buy” and a consensus price target of $15.00.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).